EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections

Marcel Lucas de Almeida iD, Ana Paula Dos Santos Matos iD, Veronica da Silva Cardoso iD, Tatielle do Nascimento, Ralph Santos-Oliveira iD, Leandro Machado Rocha iD, Francisco Paiva Machado iD, Franklin Chimaobi Kenechukwu iD, Alane Beatriz Vermelho iD, Eduardo Ricci-Júnior iD

Pharmaceutics · 17.07.2025 · 17 (7) · 925

DOI: 10.3390/pharmaceutics17070925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 17.07.2025. Verfasst von Marcel Lucas de Almeida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Desenvolvimento Galênico, Farmácia Universitária, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, FAPERJ, National Council for Scientific and Technological Development (CNPq), Carlos Chagas Filho Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Candidiasis, primarily caused by Candida albicans, and sporotrichosis, mainly caused by Sporothrix schenckii, are skin fungal infections that pose serious threats to global health. The Candida auris is a great concern in immunocompromised individuals, and while Sporothrix brasiliensis cause sporotrichosis, an infection commonly found in cats, this disease can be transmitted to humans through scratches or bites. Existing treatments for these fungal infections often cause problems related to resistance and significant side effects. Consequently, development of alternative therapeutic approaches such as nanotechnology-based topical lipid-based formulations is interesting. Thus, the objectives of this study were to prepare clove oil (CO)-in-water nanoemulsions (NEs) containing amphotericin B (AmB) and characterize them with respect to stability, release profile, and in vitro cytotoxic activity against Candida and Sporothrix strains. As a future alternative for the treatment of fungal skin diseases.

Methods

Chemical analysis of clove oil was obtained by GC-MS. The NEs were produced using an ultrasound (sonicator) method with varying proportions of CO, Pluronic® F-127, and AmB. The NEs were characterized by droplet size, morphology, stability and in vitro release profile. The antifungal and cytotoxic activity against C. albicans, C. auris, S. schenckii, and S. brasiliensis were ascertained employing agar diffusion and colorimetric MTT assay methods. A checkerboard assay was carried out using clove oil and amphotericin B against C. auris.

Results

Eugenol was the major compound identified in CO at a concentration of 80.09%. AmB-loaded NEs exhibited particle sizes smaller than 50 nm and a polydispersity index below 0.25. The optimal Ne (NEMLB-05) remained stable after 150 days of storage at 4 °C. It exhibited rapid release within the first 24 h, followed by a slow and controlled release up to 96 h. NEMLB-05 more effectively inhibited C. auris compared to free AmB and also demonstrated greater activity against C. albicans, S. schenckii, and S. brasiliensis. Clove oil and amphotericin B presented synergism inhibiting the growth of C. auris.

Conclusions

The selected CO-in-water NEs containing AmB demonstrated promising potential as a topical therapeutic alternative for treating fungal infections.

Schlagwörter

Stichwörter der Autor:innen

amphotericin Bcandidiasisclove oilin vitro release studiesnanoemulsionsporotrichosis

Autor:innen und Institutionen

  • Laboratório de Desenvolvimento Galênico, Farmácia Universitária, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.
  • Institute of Drug Technology-Farmanguinhos, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Laboratório de Biotecnologia BIOINOVAR (Unidade de Biocatálise, Bioprodutos e Bioenergia), Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.
  • Laboratory of Nanoradiopharmacy and Synthesis of Novel Radiopharmaceuticals, Nuclear Engineering Institute, Rio de Janeiro 21941-598, Brazil.
  • Laboratory of Nanoradiopharmacy and Radiopharmaceuticals, Zona Oeste State University, Rio de Janeiro 20550-013, Brazil.
  • Laboratório de Tecnologia de Produtos Naturais, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro 24210-201, Brazil.

ORCID-Profile: Marcel Lucas de Almeida, Ana Paula Dos Santos Matos, Veronica da Silva Cardoso, Ralph Santos-Oliveira, Leandro Machado Rocha, Francisco Paiva Machado, Franklin Chimaobi Kenechukwu, Alane Beatriz Vermelho, Eduardo Ricci-Júnior

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, FAPERJ
  • National Council for Scientific and Technological Development (CNPq)
  • Carlos Chagas Filho Foundation

Zitieren

APA

de Almeida, M. L., Matos, A. P. D. S., Cardoso, V. D. S., do Nascimento, T., Santos-Oliveira, R., Rocha, L. M., Machado, F. P., Kenechukwu, F. C., Vermelho, A. B., & Ricci-Júnior, E. (2025). Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections. Pharmaceutics, 17(7), 925. https://doi.org/10.3390/pharmaceutics17070925

Vancouver

de Almeida ML, Matos APDS, Cardoso VDS, do Nascimento T, Santos-Oliveira R, Rocha LM, et al. Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections. Pharmaceutics. 2025;17(7):925. doi:10.3390/pharmaceutics17070925

BibTeX
@article{deAlmeida2025,
  author = {de Almeida, Marcel Lucas and Matos, Ana Paula Dos Santos and Cardoso, Veronica da Silva and do Nascimento, Tatielle and Santos-Oliveira, Ralph and Rocha, Leandro Machado and Machado, Francisco Paiva and Kenechukwu, Franklin Chimaobi and Vermelho, Alane Beatriz and Ricci-Júnior, Eduardo},
  title = {Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {925},
  doi = {10.3390/pharmaceutics17070925}
}
Kostenlos starten →